topic0
Tumour NOS [neop] 0.00364578270237
Higher [qlco] 0.0034790309048
Groups [idcn] 0.00405169983281
Survival [acty] 0.00649679995003
Group [idcn] 0.00730184575542
resection [topp] 0.0105222460466
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.003036356879
Risk Factors [qnco] 0.00765056070301
Laparoscopic [diap] 0.00307281345906
Microvascular [ftcn] 0.00324490075727
Levels [qlco] 0.00614075191857
Performed [ftcn] 0.00417441662715
Independent [idcn] 0.00497352644168
Invasion [fndg] 0.00594822553269
Study [mnob] 0.00957459465977
Mortality [qnco] 0.00319666615118
Nonalcoholic Fatty Liver Disease [dsyn] 0.00270005863228
Methods [inpr] 0.00406693374731
METABOLIC SYNDROME [dsyn] 0.00281021106111
CANCER [neop] 0.00398919633673
Enhanced [acty] 0.00273391757626
Cases [ftcn] 0.00436915573443
Intrahepatic Cholangiocarcinoma [neop] 0.00468976573146
Post [tmco] 0.00296419925896
Cholangiocarcinoma [neop] 0.00364345010434
Liver Transplantation [topp] 0.00538250257191
YEAR [tmco] 0.00375527784976
LIVER [bpoc] 0.00647736902801
Postoperative [tmco] 0.00327312460143
Liver Cancer [neop] 0.00319443896236
CIRRHOSIS [dsyn] 0.00288361807442
treatment [ftcn] 0.00272961107427
included [ftcn] 0.00277007028061
Criteria [inpr] 0.00404102187867
Compared [acty] 0.0042664294555
liver resection [topp] 0.00416699358146
TIME [tmco] 0.00331422290732
Median [spco] 0.00312457395318
Increased [qnco] 0.00307692405827
HCC [neop] 0.00395229435641
topic1
Tumour NOS [neop] 0.00435335752707
Radiofrequency Ablation [topp] 0.00425981502302
Including [ftcn] 0.00263370413917
Survival [acty] 0.00623260069655
Group [idcn] 0.0051787143965
Based [ftcn] 0.0036698958374
CI [geoa] 0.00346221831931
HEPATITIS C VIRUS [virs] 0.00357062592823
lesions [fndg] 0.0030801031673
Prognostic [inpr] 0.00348796714641
Hepatic [blor] 0.00276003009272
Prognostic score [qnco] 0.00263507968972
Performed [ftcn] 0.00430489289301
Groups [idcn] 0.00233535146001
Independent [idcn] 0.00313906711146
Study [mnob] 0.00885441433572
Conclusions [idcn] 0.00305012894375
Pathology [bmod] 0.00269919536956
Nonalcoholic Fatty Liver Disease [dsyn] 0.00269354887119
Methods [inpr] 0.00540645472339
Risk Factors [qnco] 0.00614317253659
Cases [ftcn] 0.00366354133347
Assessed [acty] 0.00259350598958
Treated [ftcn] 0.00389728457972
YEARS [tmco] 0.0055031808135
Cholangiocarcinoma [neop] 0.00385675691177
Liver Transplantation [topp] 0.00451178368007
LIVER [bpoc] 0.00532395253702
Classification [clas] 0.002739381127
Related [qlco] 0.00471282516457
CCA [cgab] 0.00894259336005
Identified [qlco] 0.00374418865577
Odds Ratio [qnco] 0.00232054071543
treatment [ftcn] 0.00786623843013
CIRRHOSIS [dsyn] 0.00417245923464
Compared [acty] 0.00436029427846
Genes [gngm] 0.00390002650061
CANCER [neop] 0.00299947088813
Increased [qnco] 0.00302446190724
HCC [neop] 0.00427416579284
topic2
Tumour NOS [neop] 0.00425509321162
Compared [acty] 0.0044608547505
Higher [qlco] 0.00304762104943
Groups [idcn] 0.00295983040918
Survival [acty] 0.00411375340861
Group [idcn] 0.00528003539422
Based [ftcn] 0.00304965750403
Association [menp] 0.0029679212374
HEPATITIS C VIRUS [virs] 0.00761312632212
Hazard Ratio [qnco] 0.00322172739903
Levels [qlco] 0.00302636935393
LIVER [bpoc] 0.00542447620009
Performed [ftcn] 0.00416896205756
HEPATITIS B VIRUS [virs] 0.00786836869634
DIAGNOSIS [fndg] 0.00455674892963
Study [mnob] 0.00644632122167
Mortality [qnco] 0.00348334749244
Evaluate [hlca] 0.00292388762678
Conclusions [idcn] 0.00271842025337
Low [qlco] 0.00456026330497
Methods [inpr] 0.00486349377836
Enhanced [acty] 0.00268997685436
CANCER [neop] 0.00331158818104
Median [spco] 0.00291008829087
Including [ftcn] 0.00269305570173
YEARS [tmco] 0.00459408153851
included [ftcn] 0.0027980866272
Liver Transplantation [topp] 0.00353171010833
Hepatectomy [topp] 0.00344923078629
Related [qlco] 0.00904294239872
treatment [ftcn] 0.00571507035038
CIRRHOSIS [dsyn] 0.0058323870878
Complications [patf] 0.00301032038604
Transplantation [topp] 0.00316869280953
Liver Cancer [neop] 0.00446217909742
Risk Factors [qnco] 0.0138376346443
Pathology [bmod] 0.00301684768623
Tumors [neop] 0.00294895438477
Increased [qnco] 0.00322655305011
Independent [idcn] 0.00268901531343
topic3
Tumour NOS [neop] 0.00550040043368
Disease-Free Survival [qnco] 0.00285665396002
Median [spco] 0.00450764183208
Groups [idcn] 0.00435825173411
Survival [acty] 0.00794764424506
Group [idcn] 0.00654417410694
DIABETES MELLITUS [dsyn] 0.00297168534521
CI [geoa] 0.00466562886057
Hazard Ratio [qnco] 0.00423277861724
Tumour size [spco] 0.0027501985644
Fibrosis, Liver [dsyn] 0.00266179492605
LIVER [bpoc] 0.013920119713
Independent [idcn] 0.00462453054686
Study [mnob] 0.0121090519014
Mortality [qnco] 0.00330910549974
Suggest [idcn] 0.00283435219443
Conclusions [idcn] 0.00313281292251
Nonalcoholic Fatty Liver Disease [dsyn] 0.00513552902771
Methods [inpr] 0.00333566044652
Compared [acty] 0.00525689352829
Cases [ftcn] 0.006606341879
YEARS [tmco] 0.0039186012858
Higher [qlco] 0.00355549002082
control [qlco] 0.00290910620894
Nonalcoholic Steatohepatitis [dsyn] 0.00264880099091
Liver Transplantation [topp] 0.00383877582291
Hepatectomy [topp] 0.0058235844817
RATIO [qnco] 0.00256665688949
Related [qlco] 0.0037303461957
Identified [qlco] 0.00254540524454
treatment [ftcn] 0.0048309071347
CIRRHOSIS [dsyn] 0.00828343760464
FIBROSIS [patf] 0.00319232150085
Preoperative [tmco] 0.0032187201871
Levels [qlco] 0.00505601464338
Risk Factors [qnco] 0.00558862597208
Association [menp] 0.00362493726628
TIME [tmco] 0.00252479990031
Increased [qnco] 0.00480441144443
Transarterial Chemoembolization [topp] 0.00342614998368
topic4
Morbidity [qnco] 0.00284774716128
Including [ftcn] 0.00305954111688
Survival [acty] 0.00424621393047
Group [idcn] 0.00299238928652
resection [topp] 0.00515786281016
Risk Factors [qnco] 0.00754571728249
Based [ftcn] 0.00320322525129
Hazard Ratio [qnco] 0.00289739035857
Hepatic [blor] 0.00348901421344
LIVER [bpoc] 0.0100771915498
SUSTAINED VIROLOGIC RESPONSE [fndg] 0.00293618419642
Independent [idcn] 0.0056355343435
Study [mnob] 0.00915437641999
Mortality [qnco] 0.00438747791749
Conclusions [idcn] 0.00295812630345
Nonalcoholic Fatty Liver Disease [dsyn] 0.0160451475973
FIBROSIS [patf] 0.0036664581253
METABOLIC SYNDROME [dsyn] 0.00330575455304
Compared [acty] 0.00563547005254
Cases [ftcn] 0.00295047346179
Intrahepatic Cholangiocarcinoma [neop] 0.0029090540662
YEARS [tmco] 0.00453233498905
Index [inpr] 0.0038081749994
Cholangiocarcinoma [neop] 0.00347481332612
Liver Transplantation [topp] 0.00439764207911
YEAR [tmco] 0.00422850772877
Hepatectomy [topp] 0.00393105282033
Related [qlco] 0.00424131066463
control [qlco] 0.00293572033702
Postoperative [tmco] 0.00297974228754
Identified [qlco] 0.00305026978105
Progression [patf] 0.00386877653092
Odds Ratio [qnco] 0.0030909194548
treatment [ftcn] 0.00520616002333
CIRRHOSIS [dsyn] 0.00521371711797
Methods [inpr] 0.00344881725018
Fibrosis, Liver [dsyn] 0.00363788727155
Mice [mamm] 0.0033709674837
Increased [qnco] 0.00448494814824
Induced [ftcn] 0.0034638736189
topic5
Laparoscopic [diap] 0.00257711822287
Tumour NOS [neop] 0.0039789707866
ABLATION [topp] 0.00281537875584
Disease-Free Survival [qnco] 0.00257208267426
Groups [idcn] 0.0026426758126
Survival [acty] 0.0101099786316
Group [idcn] 0.00336709558039
resection [topp] 0.00269805760998
Including [ftcn] 0.00401360021424
HEPATITIS C VIRUS [virs] 0.00264666098861
Recipient [humn] 0.00335514133386
LIVER [bpoc] 0.00885157424275
Criteria [inpr] 0.0050238706787
HEPATITIS B VIRUS [virs] 0.00365769520347
Independent [idcn] 0.00303589984477
Invasion [fndg] 0.00246921339918
Study [mnob] 0.00952731539637
Post [tmco] 0.00351490286155
Nonalcoholic Fatty Liver Disease [dsyn] 0.00266338413633
Methods [inpr] 0.00491687240542
Hepatitis C virus infection [dsyn] 0.00390729860444
liver resection [topp] 0.00488150921795
PREVENT [phsu] 0.00250894611696
included [ftcn] 0.00305607342866
Mortality [qnco] 0.00499608702405
Nonalcoholic Steatohepatitis [dsyn] 0.00271222451884
Liver Transplantation [topp] 0.00830706040475
Hepatectomy [topp] 0.00387675066613
Related [qlco] 0.00543604561793
RECEIVED [qlco] 0.00360748284583
Postoperative [tmco] 0.00309689772215
Identified [qlco] 0.003075189688
treatment [ftcn] 0.00557924466879
CIRRHOSIS [dsyn] 0.00453039732504
Transplantation [topp] 0.00314213757599
Levels [qlco] 0.00277673002312
Risk Factors [qnco] 0.00969992303673
Genes [gngm] 0.00238338145173
Performed [ftcn] 0.00355674580493
SALVAGE [topp] 0.00286935252093
topic6
Tumour NOS [neop] 0.00808304878696
Higher [qlco] 0.0026477109383
bile leakage [patf] 0.00406900352524
Including [ftcn] 0.00283814140378
Survival [acty] 0.0102633571027
Group [idcn] 0.00418406230999
Based [ftcn] 0.00411418660137
CI [geoa] 0.00605845441101
HEPATITIS C VIRUS [virs] 0.00334767816528
Hazard Ratio [qnco] 0.00368938418055
Transplant [topp] 0.00288792127104
Hepatectomy [topp] 0.00631499390682
Pre [tmco] 0.00263778191054
Performed [ftcn] 0.00358404848125
Antiviral [phsu] 0.00300801237898
Independent [idcn] 0.00383632746852
Imaging [diap] 0.00399676813766
Study [mnob] 0.00591818958949
Mortality [qnco] 0.00280630030171
DIAGNOSIS [fndg] 0.00332030974027
Conclusions [idcn] 0.0038534262378
FIBROSIS [patf] 0.00936692144868
Enhanced [acty] 0.00712664333431
Compared [acty] 0.00295629585947
Cases [ftcn] 0.00472997009582
YEARS [tmco] 0.0041780973816
Contrast [irda] 0.0026878140611
Index [inpr] 0.00271515762894
Liver Transplantation [topp] 0.00485161433058
LIVER [bpoc] 0.00408745185514
RATIO [qnco] 0.0029746715521
Related [qlco] 0.0041766417843
Postoperative [tmco] 0.00560078586945
treatment [ftcn] 0.00478825139951
Methods [inpr] 0.00678740276937
Preoperative [tmco] 0.00331978315776
Risk Factors [qnco] 0.01167553197
Association [menp] 0.00295095137207
TIME [tmco] 0.00291063381245
Increased [qnco] 0.00561708955847
topic7
Tumour NOS [neop] 0.00296311817696
HCV [virs] 0.00519215424749
Treated [ftcn] 0.00278745263469
Groups [idcn] 0.00575543198454
Survival [acty] 0.0152314070068
Group [idcn] 0.00940356818923
resection [topp] 0.00920433853178
Based [ftcn] 0.0049601244615
Hazard Ratio [qnco] 0.00353409952099
Cirrhotic [qlco] 0.00294247389268
YEAR [tmco] 0.00601028261113
Hepatic [blor] 0.00455384243528
Hepatectomy [topp] 0.00376116510352
HEPATITIS B VIRUS [virs] 0.00463470211686
Observed [ftcn] 0.00296801001392
Independent [idcn] 0.00347948611024
Study [mnob] 0.00907246909206
RATIO [qnco] 0.00365447983861
Methods [inpr] 0.00823527492335
Risk Factors [qnco] 0.00724332155719
Cases [ftcn] 0.00788490118688
Including [ftcn] 0.00307421551172
YEARS [tmco] 0.00297408440101
Value [qnco] 0.00382995760236
Liver Transplantation [topp] 0.0028376201175
Stage [tmco] 0.00422623725934
LIVER [bpoc] 0.0047845086337
Conclusions [idcn] 0.00328450239872
Related [qlco] 0.00330585205067
Genotype [orga] 0.00335888202987
Postoperative [tmco] 0.00377126132671
Identified [qlco] 0.00400706482865
treatment [ftcn] 0.00619913634645
CIRRHOSIS [dsyn] 0.0058623940665
Preoperative [tmco] 0.00367557135005
Levels [qlco] 0.00428841597137
Compared [acty] 0.00631061664875
Association [menp] 0.00358379521345
Increased [qnco] 0.00456614594897
HCC [neop] 0.00336700685569
topic8
Cancers [neop] 0.004128372926
Tumour NOS [neop] 0.00284339655735
Important [qlco] 0.00336712012866
Groups [idcn] 0.00384367653788
Survival [acty] 0.00513270627879
Group [idcn] 0.00597752624026
resection [topp] 0.00287541330554
Based [ftcn] 0.00381327035615
CI [geoa] 0.00302837092023
Hazard Ratio [qnco] 0.00304381273671
Decreased [qnco] 0.00295320829851
Hepatectomy [topp] 0.0034488279087
HEPATITIS B VIRUS [virs] 0.00350112932565
Independent [idcn] 0.00300420191223
Invasion [fndg] 0.00353319035231
Study [mnob] 0.00937511466371
LOWER [spco] 0.0031527914153
Suggest [idcn] 0.00292589363401
RATIO [qnco] 0.00389101314952
Methods [inpr] 0.00432497668576
Risk Factors [qnco] 0.00628479932553
Cases [ftcn] 0.00587162983802
Intrahepatic Cholangiocarcinoma [neop] 0.00387925827044
YEARS [tmco] 0.00518149401524
Mortality [qnco] 0.003148448715
Cholangiocarcinoma [neop] 0.00362709421809
Liver Transplantation [topp] 0.00311198563898
YEAR [tmco] 0.00456227670493
LIVER [bpoc] 0.00346475174173
Related [qlco] 0.00561344880509
Post [tmco] 0.0028568656967
CCA [cgab] 0.00407813234733
Postoperative [tmco] 0.00287931808424
Odds Ratio [qnco] 0.00324761578862
treatment [ftcn] 0.00758473063968
CIRRHOSIS [dsyn] 0.0066489770195
Levels [qlco] 0.00363455692604
Compared [acty] 0.0038362726832
CANCER [neop] 0.00695098763244
Increased [qnco] 0.00436280376313
topic9
Tumour NOS [neop] 0.0039136162613
Children [aggp] 0.00300590943057
Median [spco] 0.00258245936089
Groups [idcn] 0.0031895867379
Survival [acty] 0.00739540466459
Group [idcn] 0.00676564557751
Specific [qlco] 0.0025277114185
Risk Factors [qnco] 0.00754331459911
Including [ftcn] 0.00261137860724
CI [geoa] 0.0109630122074
HEPATITIS C VIRUS [virs] 0.00324075062444
Hazard Ratio [qnco] 0.00721045173656
Hepatic [blor] 0.00248743587826
Microvascular [ftcn] 0.00626920502507
Association [menp] 0.00326054569734
HEPATITIS B VIRUS [virs] 0.00316104811436
Observed [ftcn] 0.00250979111157
DIAGNOSIS [fndg] 0.00378049783698
Invasion [fndg] 0.0085961767425
Study [mnob] 0.00827113882045
Mortality [qnco] 0.00337416675233
surveillance [ftcn] 0.00409763433039
Conclusions [idcn] 0.00373551991856
Nonalcoholic Fatty Liver Disease [dsyn] 0.0030155282011
Methods [inpr] 0.00629143244327
CANCER [neop] 0.00414780961084
Cases [ftcn] 0.00709165180213
YEARS [tmco] 0.00730819116766
Liver Transplantation [topp] 0.00269075140475
LIVER [bpoc] 0.00438336711502
Related [qlco] 0.00396676412817
Identified [qlco] 0.00337715741483
Odds Ratio [qnco] 0.00342354286251
treatment [ftcn] 0.00502569404365
CIRRHOSIS [dsyn] 0.00444410854745
Levels [qlco] 0.00400331197688
Compared [acty] 0.00454267044711
Pathology [bmod] 0.00285448318572
HCC [neop] 0.00338030748724
Independent [idcn] 0.00352764403804
